Based on the X-ray crystallography of our lead compound 1-(5-chloro-2,4-dimethoxyphenyl)-3-(5-cyanopyrazin-2-yl)urea in the checkpoint kinase 1 (Chk1) enzyme, we modified R4, and to a lesser extent, R2, and R5 of the phenyl ring, and made a variety of N-aryl-N'-pyrazinylurea Chk1 inhibitors. Enzymatic activity less than 20 nM was observed in 15 of 41 compounds. Compound 8i provided the best overall results in the cellular assays as it abrogated doxorubicin-induced cell cycle arrest (IC50=1.7 microM) and enhanced doxorubicin cytotoxicity (IC50=0.44 microM) while displaying no single agent activity.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bmcl.2006.01.028DOI Listing

Publication Analysis

Top Keywords

synthesis biological
4
biological evaluation
4
evaluation 1-245-trisubstituted
4
1-245-trisubstituted phenyl-3-5-cyanopyrazin-2-ylureas
4
phenyl-3-5-cyanopyrazin-2-ylureas potent
4
potent chk1
4
chk1 kinase
4
kinase inhibitors
4
inhibitors based
4
based x-ray
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!